Successfully reported this slideshow.
Your SlideShare is downloading. ×

Communicating Boosters for Immunocompromised and Patients at High Risk

Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Ad
Loading in …3
×

Check these out next

1 of 15 Ad
Advertisement

More Related Content

Slideshows for you (20)

Similar to Communicating Boosters for Immunocompromised and Patients at High Risk (20)

Advertisement

More from CHC Connecticut (20)

Recently uploaded (20)

Advertisement

Communicating Boosters for Immunocompromised and Patients at High Risk

  1. 1. COVID-19 Boosters and Patient Communications Leslie Gianelli Vice President, Communications Community Health Center, Inc. 1 10/20/2021
  2. 2. CHC is a leader in vaccination efforts in Connecticut • CHC built and operated Connecticut’s largest drive- through mass vaccination sites at 4 locations: East Hartford, Middletown, Danbury and Stamford. • 550,000 first and second dose vaccines have been administered since January 2021. • Mobile vaccination clinics operate in neighborhoods across the state, bringing vaccines and now boosters to workplaces, schools, houses of worship, beaches and parks. 2
  3. 3. Boosters now dominate the news 3
  4. 4. Yet, the public and patients are confused • People are receiving information from many sources about boosters and third doses • Sources may be inaccurate or misleading • Official guidance from CDC changing • “Communications crisis” as confusion leads to misinformation 4
  5. 5. Helping patients sort it all out is challenging! 5
  6. 6. Parallel Campaigns: First Doses vs. Third Doses for Immunocompromised Important Information About Booster Shots of the COVID-19 Vaccine Per the Centers for Disease Control and Prevention’s (CDC’s) recommendations, CHC is now administering booster shots of the Pfizer vaccine to established CHC patients at least 6 months after the Pfizer primary series who meet one or more of the below criteria: • 65 years and older and residents in a long-term care setting • 18-64 years with underlying medical conditions (see definition below) • 18-64 years who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting based on their individual benefit and risk *Underlying conditions for a booster dose of Pfizer include: • Cancer • Chronic kidney disease • Chronic lung diseases, including COPD (chronic obstructive pulmonary disease), asthma (moderate-to-severe), interstitial lung disease, cystic fibrosis, and pulmonary hypertension • Dementia or other neurological conditions • Diabetes (type 1 or type 2) 6
  7. 7. Important Information About a Third Dose of the COVID-19 Vaccine Per the CDC’s recommendations, CHC is now administering third doses of the Pfizer and Moderna vaccines to established CHC patients who are moderately to severely immunocompromised. At this time, only immunocompromised patients who receive their primary care services at CHC are eligible to receive a third dose of the vaccine. Patients must have received their second dose of the Pfizer or Moderna vaccine more than 28 days prior to be eligible for a third dose. Third doses will be matched with the original mRNA vaccine product received. If this is not available or unknown, either Pfizer or Moderna COVID-19 vaccine product may be administered. To receive a third dose at this time, you must be an established CHC patient who meets one or more of the below criteria. At this time we are not able to give you a third dose if you came to us for a COVID-19 test or vaccine but have not established CHC as your primary care provider and visited us for a primary care service. Parallel Campaigns: First Doses vs. Third Doses for Immunocompromised 7
  8. 8. Start with trusted sources within your organization • Providers and front line staff • Direct to patient communications via email and text • Recorded phone messages • Call center • Website 8
  9. 9. Social Media 9
  10. 10. Working with Community Partners 10
  11. 11. Resources 11
  12. 12. Resources Vaccine Booster Doses COVID-19 Booster Dose Updates as of October 15, 2021 Topline message: On October 14-15, FDA advisors made new recommendations on booster doses. Topline messages and takeaways on the current status of COVID-19 booster doses The vaccines work. The COVID-19 vaccines continue to be remarkably effective in reducing risk of severe disease, hospitalization, and death, including against the delta variant. We continue to see highly effective protection against hospitalizations and severe outcomes for people who are fully vaccinated. 12
  13. 13. Resources 13
  14. 14. CHCradio.com Conversations on Health Care Recent Guests: Former FDA Commissioner Dr. Scott Gottlieb (Oct. 5) NIH Director Dr. Francis Collins (Sept. 8) Kentucky Governor Andy Beshear (Aug. 26) CNN Analyst Dr. Leana Wen (Aug. 2) Dr. Anthony Fauci (June 15) CDC Director Rochelle Walensky (May 17) Upcoming: US Surgeon General Vivek Murthy 14
  15. 15. COVID-19 Boosters and Patient Communications leslie@chc1.com 15

×